FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012030912> ?p ?o ?g. }

• W2012030912 endingPage "917" @default.
• W2012030912 startingPage "909" @default.
• W2012030912 abstract "Background: Preliminary data suggest that short‐term antibiotic therapy with a single drug is effective for the treatment of patients with pouchitis. However, some patients are resistant to treatment. Aim: To evaluate the therapeutic efficacy of a prolonged course of a combination of two antibiotics in patients with refractory or recurrent pouchitis, as well as its impact on their quality of life. Methods: Patients with active refractory or recurrent pouchitis were recruited. This was defined as both: (i) a history of pouchitis at least twice in the last 12 months or persistent pouchitis requiring continual intake of antibiotics; and (ii) a Pouchitis Disease Activity Index score 3 7 (best to worst pouchitis=0–18) at the beginning of therapy. Treatment consisted of a combination of metronidazole, 400 or 500 mg twice daily, and ciprofloxacin, 500 mg twice daily, for 28 days. Symptomatic, endoscopic and histological evaluations were undertaken before and after antibiotic therapy using the Pouchitis Disease Activity Index score. Remission was defined as a combination of a Pouchitis Disease Activity Index clinical score of 2, endoscopic score of 1 and total score of 4. The quality of life was assessed with the Inflammatory Bowel Disease Questionnaire, which encompasses bowel, systemic and emotional symptoms as well as social function (worst to best=32–224). Results: Forty‐four patients (24 male, 20 female; median age, 37.5 years) entered the trial and completed treatment. Thirty‐six (82%) went into remission. The median Pouchitis Disease Activity Index scores before and after therapy were 12 (range, 8–17) and 3 (range, 1–10), respectively ( P < 0.0001). The median Inflammatory Bowel Disease Questionnaire score also significantly improved from 96.5 (range, 74–183) to 175 (range, 76–215) with this therapy ( P < 0.0001). The eight patients (five male, three female) who did not go into remission were significantly older (median 47.5 vs. 35 years; P =0.007), had a longer history of pouchitis (95.5 vs. 26 months; P =0.0008), had a greater proportion with chronic pouchitis (chronic/relapsing: 6/2 vs. 9/27; relative risk, 1.6; 95% confidence interval, 1.0–2.4) and tended to have a higher Pouchitis Disease Activity Index score before treatment (median 14.5 vs. 12; P =0.13) than those who went into remission. Even in these eight patients, the median Pouchitis Disease Activity Index score significantly improved from 14.5 (range, 8–16) to 9.5 (range, 7–10) ( P =0.0078), as did the Inflammatory Bowel Disease Questionnaire score from 95.5 (range, 74–134) to 127 (range, 76–187) ( P =0.039). The Inflammatory Bowel Disease Questionnaire score strongly correlated with the Pouchitis Disease Activity Index score ( r =0.79, P < 0.0001), and was significantly related to the patients' overall assessment of satisfaction ( P < 0.0001). No serious side‐effects were noted. Conclusions: Four‐week treatment with a combination of metronidazole and ciprofloxacin is highly effective in patients with active recurrent or refractory pouchitis, objectively improving the inflammation and quality of life. The Inflammatory Bowel Disease Questionnaire is a sensitive tool for evaluating patients with pouchitis, and correlates well with disease activity." @default.
• W2012030912 created "2016-06-24" @default.
• W2012030912 creator A5009158076 @default.
• W2012030912 creator A5022137060 @default.
• W2012030912 creator A5027006001 @default.
• W2012030912 creator A5040465224 @default.
• W2012030912 creator A5057494980 @default.
• W2012030912 creator A5059435501 @default.
• W2012030912 creator A5070057686 @default.
• W2012030912 creator A5071390402 @default.
• W2012030912 creator A5081952210 @default.
• W2012030912 creator A5085647688 @default.
• W2012030912 date "2002-04-27" @default.
• W2012030912 modified "2023-10-14" @default.
• W2012030912 title "Four‐week open‐label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis" @default.
• W2012030912 cites W1953831249 @default.
• W2012030912 cites W1970396368 @default.
• W2012030912 cites W1992808215 @default.
• W2012030912 cites W2007838388 @default.
• W2012030912 cites W2021003964 @default.
• W2012030912 cites W2024497422 @default.
• W2012030912 cites W2031512696 @default.
• W2012030912 cites W2049779424 @default.
• W2012030912 cites W2053083773 @default.
• W2012030912 cites W2057771510 @default.
• W2012030912 cites W2058616057 @default.
• W2012030912 cites W2063512218 @default.
• W2012030912 cites W2085240670 @default.
• W2012030912 cites W2086047585 @default.
• W2012030912 cites W2090827976 @default.
• W2012030912 cites W2090853704 @default.
• W2012030912 cites W2091250795 @default.
• W2012030912 cites W2091772704 @default.
• W2012030912 cites W2094682242 @default.
• W2012030912 cites W2115778673 @default.
• W2012030912 cites W2159120383 @default.
• W2012030912 cites W2163369145 @default.
• W2012030912 cites W2167111506 @default.
• W2012030912 cites W4231456852 @default.
• W2012030912 cites W4239256900 @default.
• W2012030912 doi "https://doi.org/10.1046/j.1365-2036.2002.01203.x" @default.
• W2012030912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11966499" @default.
• W2012030912 hasPublicationYear "2002" @default.
• W2012030912 type Work @default.
• W2012030912 sameAs 2012030912 @default.
• W2012030912 citedByCount "194" @default.
• W2012030912 countsByYear W20120309122012 @default.
• W2012030912 countsByYear W20120309122013 @default.
• W2012030912 countsByYear W20120309122014 @default.
• W2012030912 countsByYear W20120309122015 @default.
• W2012030912 countsByYear W20120309122016 @default.
• W2012030912 countsByYear W20120309122017 @default.
• W2012030912 countsByYear W20120309122018 @default.
• W2012030912 countsByYear W20120309122019 @default.
• W2012030912 countsByYear W20120309122020 @default.
• W2012030912 countsByYear W20120309122021 @default.
• W2012030912 countsByYear W20120309122022 @default.
• W2012030912 countsByYear W20120309122023 @default.
• W2012030912 crossrefType "journal-article" @default.
• W2012030912 hasAuthorship W2012030912A5009158076 @default.
• W2012030912 hasAuthorship W2012030912A5022137060 @default.
• W2012030912 hasAuthorship W2012030912A5027006001 @default.
• W2012030912 hasAuthorship W2012030912A5040465224 @default.
• W2012030912 hasAuthorship W2012030912A5057494980 @default.
• W2012030912 hasAuthorship W2012030912A5059435501 @default.
• W2012030912 hasAuthorship W2012030912A5070057686 @default.
• W2012030912 hasAuthorship W2012030912A5071390402 @default.
• W2012030912 hasAuthorship W2012030912A5081952210 @default.
• W2012030912 hasAuthorship W2012030912A5085647688 @default.
• W2012030912 hasBestOaLocation W20120309121 @default.
• W2012030912 hasConcept C121332964 @default.
• W2012030912 hasConcept C126322002 @default.
• W2012030912 hasConcept C141071460 @default.
• W2012030912 hasConcept C142424586 @default.
• W2012030912 hasConcept C159110408 @default.
• W2012030912 hasConcept C2777396551 @default.
• W2012030912 hasConcept C2778260677 @default.
• W2012030912 hasConcept C2779134260 @default.
• W2012030912 hasConcept C2779454807 @default.
• W2012030912 hasConcept C2779951463 @default.
• W2012030912 hasConcept C501593827 @default.
• W2012030912 hasConcept C535046627 @default.
• W2012030912 hasConcept C71924100 @default.
• W2012030912 hasConcept C86803240 @default.
• W2012030912 hasConcept C87355193 @default.
• W2012030912 hasConcept C89423630 @default.
• W2012030912 hasConcept C90924648 @default.
• W2012030912 hasConceptScore W2012030912C121332964 @default.
• W2012030912 hasConceptScore W2012030912C126322002 @default.
• W2012030912 hasConceptScore W2012030912C141071460 @default.
• W2012030912 hasConceptScore W2012030912C142424586 @default.
• W2012030912 hasConceptScore W2012030912C159110408 @default.
• W2012030912 hasConceptScore W2012030912C2777396551 @default.
• W2012030912 hasConceptScore W2012030912C2778260677 @default.
• W2012030912 hasConceptScore W2012030912C2779134260 @default.
• W2012030912 hasConceptScore W2012030912C2779454807 @default.
• W2012030912 hasConceptScore W2012030912C2779951463 @default.
• W2012030912 hasConceptScore W2012030912C501593827 @default.

• next